Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
51,136,131
-
Number of holders
-
173
-
Total 13F shares, excl. options
-
35,093,974
-
Shares change
-
-1,212,078
-
Total reported value, excl. options
-
$927,284,018
-
Value change
-
-$30,479,732
-
Put/Call ratio
-
62%
-
Number of buys
-
89
-
Number of sells
-
-65
-
Price
-
$26.43
Significant Holders of REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) as of Q3 2022
193 filings reported holding RGNX - REGENXBIO Inc. - Common Stock, par value $0.0001 per share as of Q3 2022.
REGENXBIO Inc. - Common Stock, par value $0.0001 per share (RGNX) has 173 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35,093,974 shares
of 51,136,131 outstanding shares and own 69% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6,551,276 shares), VANGUARD GROUP INC (4,267,542 shares), JPMORGAN CHASE & CO (4,054,655 shares), STATE STREET CORP (2,620,104 shares), Redmile Group, LLC (1,917,212 shares), RTW INVESTMENTS, LP (1,845,366 shares), DIMENSIONAL FUND ADVISORS LP (1,254,101 shares), Aquilo Capital Management, LLC (967,684 shares), GEODE CAPITAL MANAGEMENT, LLC (707,573 shares), and FIRST MANHATTAN CO (705,730 shares).
This table shows the top 173 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.